Anastrozole, initially developed for breast cancer treatment in postmenopausal women, is gaining attention for off-label use in men to manage estrogen-related conditions like gynecomastia and male infertility. By inhibiting the aromatase enzyme, it lowers estrogen levels, promoting hormonal balance. However, potential side effects like joint pain and decreased bone density necessitate medical supervision.
Anastrozole is a medication used to treat breast cancer in postmenopausal women. It effectively inhibits the aromatase enzyme, reducing estrogen production. Common side effects include hot flashes, joint pain, fatigue, mood changes, and bone density loss, potentially increasing fracture risk. Less frequent but more severe effects may involve liver changes, higher cholesterol levels, and cardiovascular issues. Patients should discuss any symptoms with their healthcare provider to manage side effects and ensure effective treatment.
